Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Allen Furlan who wrote (8163)	9/7/1999 12:24:00 PM
From: Terrapin	Read Replies (1) \| Respond to of 78822

Thread RE: APCC I have been watching this one but missed the nice gains of a few months ago. While I do not view it to be particularly undervalued at this point it appears to be financially healthy and reasonably well managed. I was surprised recently to see that they had passed a poison pill despite the lack of any obvious hostile suitor. So my first question is specific: did I miss something with APCC that would trigger the BoD to do this? My second question is more broad: how does one evaluate this type of move in a company? I have seen it before in 'special situations' companies that run into trouble and become entrenched. Has anyone run across it in a company that is perceived to be healthy? Any comments appreciated, Terrapin ps: I tried to post this over the weekend but it never showed so I apologize in advance if it shows up later :)